PTC Inc PTC
$195.10 −$0.53 (-0.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $195.10 0.00%
Open$195.43
Prev close$195.63
Day range$194.76 – $196.25
Volume2.45M
Market cap$21.19B
P/E (TTM)21.8
Dividend yield–
PTC Stock News
Headlines matching PTC Inc or the PTC ticker, most recent first.
- KeyBanc Maintains PTC Inc(PTC.US) With Buy Rating
- Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $137 Positive
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $109
- PTC Insiders Sold US$9.1m Of Shares Suggesting Hesitancy
- Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $120
- Berenberg Bank Maintains PTC Inc(PTC.US) With Hold Rating, Maintains Target Price $170
- TD Cowen Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $90
- Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $122 Positive
- Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $130
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $109 Positive
- BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $96
- Goldman Sachs Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $70 Positive
- A Quick Look at Today's Ratings for PTC Inc(PTC.US), With a Forecast Between $141 to $205
- Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $106
- Citi Maintains PTC Inc(PTC.US) With Hold Rating, Raises Target Price to $141 Positive
No comments yet — be the first to weigh in on PTC.
Sign in to join the discussion.